TransCode Therapeutics Inc

NASDAQ:RNAZ   3:59:54 PM EDT
2.73
0.00 (0.00%)
Other Pre-Announcement

TransCode Therapeutics Reports Q3 Loss Per Share $0.20

Published: 11/15/2021 21:21 GMT
TransCode Therapeutics Inc (RNAZ) - Transcode Therapeutics Reports Business Progress and Third Quarter 2021 Financial Results.
Q3 Loss per Share $0.20.
Transcode Therapeutics - Expects Cash, Equivalents As of Sept 30, 2021, Sufficient to Fund Planned Operations Through Year-end 2022.
Expects That Operating Losses Will Increase Substantially in Foreseeable Future.